Published in Eur J Immunol on March 01, 2004
CD4+ Tregs and immune control. J Clin Invest (2004) 2.85
Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun (2005) 2.33
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood (2009) 1.93
Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc Natl Acad Sci U S A (2007) 1.82
The development and function of regulatory T cells. Cell Mol Life Sci (2009) 1.66
Myeloid dendritic cells isolated from tissues of SIV-infected Rhesus macaques promote the induction of regulatory T cells. AIDS (2012) 1.50
Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system. J Virol (2007) 1.21
Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons. Immunol Res (2010) 1.06
FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease. Clin Exp Immunol (2005) 1.04
Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo. Immunology (2008) 1.02
Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification. Endocr Metab Immune Disord Drug Targets (2009) 1.01
Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples. J Immunother (2005) 1.00
Immunosuppression induced by immature dendritic cells is mediated by TGF-beta/IL-10 double-positive CD4+ regulatory T cells. J Cell Mol Med (2008) 1.00
The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance. Clin Dev Immunol (2011) 0.99
Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids. Clin Dev Immunol (2008) 0.98
Regulating the immune system: the induction of regulatory T cells in the periphery. Arthritis Res Ther (2004) 0.98
Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities. Immunology (2006) 0.96
Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases. Arthritis Res Ther (2005) 0.96
T regulatory cells: aid or hindrance in the clearance of disease? J Cell Mol Med (2008) 0.93
Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders. Clin Exp Immunol (2007) 0.92
Recent advances in dendritic cell biology. J Clin Immunol (2005) 0.92
Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii. Immunol Res (2009) 0.91
Translating tolerogenic therapies to the clinic - where do we stand? Front Immunol (2012) 0.91
CD4+ regulatory cells as a potential immunotherapy. Philos Trans R Soc Lond B Biol Sci (2005) 0.90
Systemic administration of tolerogenic dendritic cells ameliorates murine inflammatory arthritis. Open Rheumatol J (2008) 0.87
Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo. Clin Exp Immunol (2010) 0.87
The effects of renal transplantation on circulating dendritic cells. Clin Exp Immunol (2005) 0.84
Transplant tolerance: new insights and strategies for long-term allograft acceptance. Clin Dev Immunol (2013) 0.80
In vitro HIV infection impairs the capacity of myeloid dendritic cells to induce regulatory T cells. PLoS One (2012) 0.80
Experimental study of the mechanism of tolerance induction in dexamethasone-treated dendritic cells. Med Sci Monit (2011) 0.78
Activation-induced FoxP3 expression regulates cytokine production in conventional T cells stimulated with autologous dendritic cells. Clin Vaccine Immunol (2012) 0.75
Human CD4(+) effector T lymphocytes generated upon TCR engagement with self-peptides respond defectively to IL-7 in their transition to memory cells. Cell Mol Immunol (2013) 0.75
Effects of Foxp3 gene modified dendritic cells on mouse corneal allograft rejection. Int J Clin Exp Med (2015) 0.75
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med (2005) 10.16
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 3.41
IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol (2004) 2.59
AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol (2009) 2.49
Gamma-globulin levels in patients with community-acquired septic shock. Shock (2009) 2.21
Challenges with advanced therapy medicinal products and how to meet them. Nat Rev Drug Discov (2010) 2.09
CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice. Hepatology (2005) 1.88
Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin North Am (2007) 1.85
Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun (2003) 1.74
A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J Exp Med (2004) 1.71
Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology (2006) 1.68
Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression. Transplantation (2005) 1.66
How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol (2008) 1.65
IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human. Eur J Immunol (2005) 1.59
Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion. Liver Transpl (2006) 1.57
Cytokine mRNA quantification by real-time PCR. J Immunol Methods (2002) 1.56
Hypereosinophilic syndromes. Orphanet J Rare Dis (2007) 1.53
Double-stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells. J Biol Chem (2004) 1.44
Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med (2010) 1.39
Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS One (2010) 1.37
Monophosphoryl lipid A activates both human dendritic cells and T cells. J Immunol (2002) 1.36
Preferential production of the IL-12(p40)/IL-23(p19) heterodimer by dendritic cells from human newborns. Eur J Immunol (2006) 1.35
High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome. J Allergy Clin Immunol (2002) 1.34
Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. J Immunol (2010) 1.34
Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis. Cell Transplant (2010) 1.34
Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood (2003) 1.32
Human gamma delta T cells induce dendritic cell maturation. Clin Immunol (2002) 1.29
Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway. PLoS One (2007) 1.27
IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. J Immunol (2007) 1.26
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome. J Allergy Clin Immunol (2010) 1.25
The hypereosinophilic syndrome revisited. Annu Rev Med (2001) 1.25
Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells. Eur J Immunol (2008) 1.24
Vaccination and autoimmune disease: what is the evidence? Lancet (2003) 1.22
Multiple pathways to allograft rejection. Transplantation (2002) 1.21
Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood (2005) 1.20
Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites. Blood (2003) 1.19
Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells (2005) 1.19
Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4. Eur J Immunol (2005) 1.17
Antigen-specific central memory CD4+ T lymphocytes produce multiple cytokines and proliferate in vivo in humans. J Immunol (2006) 1.17
Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood (2007) 1.17
Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. Hum Immunol (2010) 1.17
Monitoring of cellular responses after vaccination against tetanus toxoid: comparison of the measurement of IFN-gamma production by ELISA, ELISPOT, flow cytometry and real-time PCR. J Immunol Methods (2005) 1.16
Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process. J Immunol (2010) 1.15
Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes (2008) 1.14
Fostering responsible data sharing through standards. N Engl J Med (2014) 1.11
CD4+CD25+ and CD4+CD25- T cells act respectively as inducer and effector T suppressor cells in superantigen-induced tolerance. J Immunol (2003) 1.10
Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways. Blood (2009) 1.07
Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. Int J Biochem Cell Biol (2004) 1.05
Interleukin-12 family members and the balance between rejection and tolerance. Curr Opin Organ Transplant (2008) 1.04
Anaphylactic shock caused by immunoglobulin E sensitization after retreatment with the chimeric anti-interleukin-2 receptor monoclonal antibody basiliximab. Transplantation (2003) 1.04
Immune monitoring in whole blood using real-time PCR. J Immunol Methods (2003) 1.02
Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood (2005) 1.02
6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome. Haematologica (2005) 1.01
Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants. Semin Respir Crit Care Med (2006) 1.01
The multiple facets of toll-like receptors in transplantation biology. Transplantation (2008) 0.99
Optimal kinetics for quantification of antigen-induced cytokines in human peripheral blood mononuclear cells by real-time PCR and by ELISA. J Immunol Methods (2003) 0.99
ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia. PLoS Pathog (2011) 0.99
Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. Eur J Immunol (2002) 0.98
111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content. Eur J Nucl Med Mol Imaging (2003) 0.98
PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells. Eur J Immunol (2010) 0.98
Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties. Blood (2002) 0.97
The occurrence of severe sepsis and septic shock are related to distinct patterns of cytokine gene expression. Shock (2006) 0.96
Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. Gastroenterology (2002) 0.96
Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes. Int Immunol (2002) 0.96
Tissue factor-dependent procoagulant activity of isolated human hepatocytes: relevance to liver cell transplantation. Liver Transpl (2007) 0.96
Cellular mechanisms underlying acute graft rejection: time for reassessment. Curr Opin Immunol (2007) 0.95
IL-12 and type I IFN response of neonatal myeloid DC to human CMV infection. Eur J Immunol (2009) 0.95
Critical role of protein kinase C epsilon for lipopolysaccharide-induced IL-12 synthesis in monocyte-derived dendritic cells. Eur J Immunol (2002) 0.93
The rational use of animals in drug development: contribution of the innovative medicines initiative. Altern Lab Anim (2012) 0.92
Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns. Eur J Immunol (2002) 0.92
Rottlerin inhibits human T cell responses. Biochem Pharmacol (2006) 0.91
Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis. J Biol Chem (2007) 0.91
Astrocytes are an early target in osmotic demyelination syndrome. J Am Soc Nephrol (2011) 0.91
Characterization of a subset of antigen-specific human central memory CD4+ T lymphocytes producing effector cytokines. Eur J Immunol (2008) 0.91
Genetically modified stem cells for the treatment of neurological diseases. Front Biosci (Elite Ed) (2012) 0.90
A critical role for p53 in the control of NF-kappaB-dependent gene expression in TLR4-stimulated dendritic cells exposed to Genistein. J Immunol (2007) 0.90
TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas. Leuk Res (2008) 0.90
IL-6 produced by type I IFN DC controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells. Hum Immunol (2005) 0.90
DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4. Eur J Immunol (2008) 0.89
Human pancreatic duct cells exert tissue factor-dependent procoagulant activity: relevance to islet transplantation. Diabetes (2004) 0.89
Analysis of the peripheral T-cell repertoire in kidney transplant patients. Eur J Immunol (2010) 0.89
An alternative pathway of NF-kappaB activation results in maturation and T cell priming activity of dendritic cells overexpressing a mutated IkappaBalpha. J Immunol (2007) 0.89
The chemerin/ChemR23 system does not affect the pro-inflammatory response of mouse and human macrophages ex vivo. PLoS One (2012) 0.89
Interleukin-9 promotes eosinophilic rejection of mouse heart allografts. Transplantation (2003) 0.89
In vivo morphological changes in animal models of amyotrophic lateral sclerosis and Alzheimer's-like disease: MRI approach. Anat Rec (Hoboken) (2009) 0.89
IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17. J Leukoc Biol (2011) 0.89
Alteration of migration and maturation of dendritic cells and T-cell depletion in the course of experimental Trypanosoma cruzi infection. Lab Invest (2003) 0.88
IL-17 production elicited by allo-major histocompatibility complex class II recognition depends on CD25posCD4pos T cells. Transplantation (2008) 0.88
Interferon regulatory factor 3 deficiency leads to interleukin-17-mediated liver ischemia-reperfusion injury. Hepatology (2012) 0.88
Amplification of T-cell responses by neutrophils: relevance to allograft immunity. Immunol Lett (2004) 0.88
Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction? Am J Transplant (2003) 0.87